tiletamine hydrochloride has been researched along with Apoplexy in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Listing, J; Manger, B; Meissner, Y; Richter, A; Strangfeld, A; Tony, HP; Wilden, E; Zink, A | 1 |
1 other study(ies) available for tiletamine hydrochloride and Apoplexy
Article | Year |
---|---|
Serious adverse events and the risk of stroke in patients with rheumatoid arthritis: results from the German RABBIT cohort.
Topics: Adult; Age Factors; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Cardiovascular Diseases; Case-Control Studies; Cyclohexanones; Female; Germany; Humans; Hypolipoproteinemias; Immunocompromised Host; Incidence; Infections; Ischemic Attack, Transient; Male; Middle Aged; Phenols; Proportional Hazards Models; Registries; Risk Factors; Smoking; Stroke | 2017 |